Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study
Published
A booster dose of the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE restored efficacy to 95.6% against the...
Full ArticlePublished
A booster dose of the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE restored efficacy to 95.6% against the...
Full ArticleWatch VideoThe Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19..